probenecid has been researched along with Raynaud Disease in 1 studies
Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.
Raynaud Disease: An idiopathic vascular disorder characterized by bilateral Raynaud phenomenon, the abrupt onset of digital paleness or CYANOSIS in response to cold exposure or stress.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with probenecid and intra-arterial injection of reserpine resulted in considerable improvement." | 1.26 | Treatment of calcinosis circumscripta and Raynaud's phenomenon. ( Meyers, D, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Meyers, D | 1 |
1 other study available for probenecid and Raynaud Disease
| Article | Year |
|---|---|
Treatment of calcinosis circumscripta and Raynaud's phenomenon.
Topics: Calcinosis; Female; Humans; Middle Aged; Probenecid; Raynaud Disease; Reserpine | 1976 |